<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02051114</url>
  </required_header>
  <id_info>
    <org_study_id>DOR-0833</org_study_id>
    <nct_id>NCT02051114</nct_id>
  </id_info>
  <brief_title>Discovering the Antecedents of Rheumatoid Arthritis Flare</brief_title>
  <official_title>Discovering the Antecedents of Rheumatoid Arthritis Flare</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rockefeller University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rockefeller University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Longitudinal study of patients with rheumatoid arthritis comparing measures of disease
      activity with blood samples.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      80% of patients living with rheumatoid arthritis can expect fluctuations in their symptoms
      over time. Dramatic increases in disease activity are considered flare. This study will
      follow patients with increased risk for flare prospectively for one year. Serial
      questionnaires and disease activity scores will be compared to blood samples to better
      understand the molecular phenotype of rheumatoid arthritis flares.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>RNA transcripts that correlate with rheumatoid arthritis disease activity</measure>
    <time_frame>1 year</time_frame>
    <description>Blood drawn at various times throughout one year will be correlated with fluctuations in RA disease activity.</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Rheumatoid Arthritis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  2010 criteria for Rheumatoid Arthritis

          -  Swelling of at least one joint and or elevated acute phase reactants

          -  Greater than or equal to 40 years old or less than or equal to 65 year old female sex

          -  cyclic citrullinated peptide antibody + in the past 12 months

        Exclusion Criteria:

          -  hemoglobin &lt; 9

          -  white blood cell count &lt; 3.5

          -  Diagnosis of any active malignancy within the last 3 years besides non-melanomatous
             skin cancer

          -  Diagnosis of diabetes and requires insulin

          -  HIV+, Hep B S Ag+, Hep C polymerase chain reaction +

          -  Untreated latent tuberculosis

          -  Diagnosis of any additional systemic autoimmune connective tissue disease

          -  Inability to reliably complete study requirements

          -  History, physical, social or laboratory findings suggestive of any other medical or
             psychological condition that would, in the opinion of the principal investigator, make
             the candidate ineligible for the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana E Orange, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Rockefeller University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Recruitment Specialist</last_name>
    <phone>1-800-782-2737</phone>
    <email>RUcares@rockefeller.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Rockefeller University Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dana E Orange, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rockefeller University</investigator_affiliation>
    <investigator_full_name>Dana Orange</investigator_full_name>
    <investigator_title>Instructor in Clinical Investigation</investigator_title>
  </responsible_party>
  <keyword>Rheumatoid arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

